Inflammatory arthritis describes a group of diseases caused by an overactive immune system. The different types of inflammatory arthritis include rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. The most common symptoms are joint pain and stiffness. Pain is the predominant symptom in the majority of people with inflammatory arthritis, which contributes to the global burden of rheumatic and musculoskeletal conditions.1 Knowledgeable support can reduce pain, increase functioning and well-being, and reduce individual and societal costs.1
Co-creation is a collaborative development strategy where stakeholders from different backgrounds or sectors work together to jointly produce a mutually valued outcome. Cross-sectoral cooperation in healthcare systems involves collaboration among various sectors – public, private, and non-profit – to address health-related issues in a comprehensive and effective manner. Cross-sectoral cooperation is vital in the management of people living with inflammatory arthritis because it enables integrated care approaches that enhance patient outcomes by combining expertise from various healthcare and support services. Cross-sectoral cooperation can lead to innovative treatments and more coherent and coordinated patient pathways, ultimately improving quality of life for patients with this chronic condition.
To explore and facilitate cross sectoral collaboration, a 1-day seminar was held to bring together a group of 53 stakeholders with different backgrounds and interests, including multidisciplinary healthcare professionals and general practitioners, municipal representatives, politicians, public leaders, and patient research partners. The aim was to inspire dialogue on how management across these different sectors can improve and develop healthcare for people with an inflammatory arthritis. The meeting delivered state-of-the art updates about the latest research on co-creation, public governance, cross-sectoral management, and relational capacity. After the seminar, a survey captured feedback on how participants perceived the overall benefit from the seminar, and the degree to which their expectations were met.
Of 22 responses collected, 100% rated the outcomes of the seminar as ‘good’ or ‘very good’. 59% and 36% felt that the meeting met their expectations to a ‘high degree’ or ‘very high degree’, while 5% were neutral. There was a feeling that there is a pressing need to improve the cross-sectoral cooperation in order to manage the complexity of people with inflammatory arthritis, and that some of the ideas presented would be useful as a tool to improve communication and collaboration – both internally, and with external partners.
The authors feel that the seminar was successful in addressing the need to improve coherence across sectors. This is the first step in a continuous process, and future efforts will involve patients and other stakeholders from all parts of the healthcare system to improve the cross-sectoral cooperation.
Source
Fabricius Petersen B, et al. Improving cross-sectoral care for patients with inflammatory arthritis: results from a first seminar with cross-sectoral involvement. Presented at EULAR 2024; OP0318-PARE.
Ann Rheum Dis 2024; DOI: 10.1136/annrheumdis-2024-eular.5801.
References
1. Geenen R, et al. EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis 2018;77:797–807.
About EULAR
EULAR is the European umbrella organisation representing scientific societies, health professional associations and organisations for people with rheumatic and musculoskeletal diseases (RMDs). EULAR aims to reduce the impact of RMDs on individuals and society, as well as improve RMD treatments, prevention, and rehabilitation. To this end, EULAR fosters excellence in rheumatology education and research, promotes the translation of research advances into daily care, and advocates for the recognition of the needs of those living with RMDs by EU institutions.